J Vermylen Selected Research

Fibronectins (Fibronectin)

6/2004

alphaIIbbeta3 antagonism vs. antiadhesive treatment to prevent platelet interactions with vascular subendothelium.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Vermylen Research Topics

Disease

7	Thrombosis (Thrombus) 01/2007 - 07/2000
3	Thrombocytopenia (Thrombopenia) 01/2007 - 02/2001
3	Hemophilia A (Haemophilia) 08/2000 - 01/2000
2	Myocardial Infarction 09/2005 - 09/2002
2	Inflammation (Inflammations) 06/2004 - 02/2001
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 05/2003 - 03/2002
2	Hemorrhage 09/2001 - 08/2001
1	Vascular System Injuries 01/2006
1	Pneumonia (Pneumonitis) 09/2005
1	Arteriovenous Fistula 06/2002
1	False Aneurysm (Pseudoaneurysm) 06/2002
1	Renal Colic 06/2002
1	Flank Pain 06/2002
1	Blue Toe Syndrome 03/2002
1	Venous Thrombosis (Deep-Vein Thrombosis) 03/2002
1	Spontaneous Abortion (Miscarriage) 03/2002
1	Congenital Disorders of Glycosylation 08/2001
1	Congenital disorder of glycosylation type 2A 08/2001
1	Neointima 02/2001
1	Pathologic Constriction (Stenosis) 02/2001

Drug/Important Bio-Agent (IBA)

5	AntibodiesIBA 05/2003 - 01/2000
2	Heparin (Liquaemin)FDA LinkGeneric 01/2007 - 05/2006
2	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 01/2007 - 03/2002
2	Antiphospholipid AntibodiesIBA 05/2003 - 03/2002
2	Factor VIII (Coagulation Factor VIII)IBA 08/2000 - 01/2000
1	AnticoagulantsIBA 01/2007
1	AntithrombinsIBA 05/2006
1	Adenosine Triphosphate (ATP)IBA 01/2006
1	Adenosine Diphosphate (ADP)IBA 01/2006
1	Adenine NucleotidesIBA 01/2006
1	Environmental Pollutants (Pollutants, Environmental)IBA 09/2005
1	Fibronectins (Fibronectin)IBA 06/2004
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2004
1	AminesIBA 09/2002
1	Biological ProductsIBA 09/2002
1	Particulate MatterIBA 09/2002
1	Polystyrenes (Polystyrene)IBA 09/2002
1	Antigen-Antibody Complex (Immune Complex)IBA 03/2002
1	Vitamin K FDA Link 03/2002
1	Phenprocoumon (Liquamar)FDA Link 03/2002
1	GTP-Binding Protein alpha SubunitsIBA 09/2001
1	Neuraminidase (Sialidase)IBA 08/2001
1	LectinsIBA 08/2001
1	Glycoproteins (Glycoprotein)IBA 08/2001
1	Galactose (Galactopyranose)FDA LinkGeneric 08/2001
1	beta- 1,3- galactosyl- 0- glycosyl- glycoprotein beta-1,3-N-acetylglucosaminyltransferaseIBA 08/2001
1	EnzymesIBA 08/2001
1	CollagenIBA 08/2001
1	Blood Coagulation Factors (Coagulation Factor)IBA 08/2001
1	phosphomannomutaseIBA 08/2001
1	Ancrod (Arvin)IBA 02/2001
1	Busulfan (Busulfex)FDA Link 02/2001
1	FibrinIBA 02/2001
1	Fibrinogen (Factor I)FDA Link 02/2001
1	Phenobarbital (Luminal)FDA Link 02/2001
1	Thromboplastin (Tissue Factor)IBA 02/2001
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 02/2001
1	von Willebrand FactorIBA 08/2000
1	Plasminogen Activator Inhibitor 1IBA 07/2000
1	Plasminogen Activators (Plasminogen Activator)IBA 07/2000
1	AutoantigensIBA 06/2000

Therapy/Procedure

1	Splenectomy 06/2002
1	Ligation 02/2001
1	Therapeutics 01/2000